Biography

Richard Williams has worked at the Kennedy Institute of Rheumatology since 1989 and was a Senior Lecturer (2007-2011) and then Reader (2011-2012) at Imperial College London before joining the University of Oxford. He is also a Visiting Lecturer at University College London, Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Arthritis Research and Therapy. He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics. He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis. Research Interests: Rheumatology He published more than 100 papers.

Research Intrest

Rheumatology

List of Publications
"1. Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells J Exp Med (2008) 205: 2491-2497 2. Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis Arthritis Rheum (2009) 60: 1342-1351 3. Alzabin S, Abraham SM, Taher TE, Palfreeman A, Hull D, McNamee K, Jawad A, Pathan E, Kinderlerer A, Taylor PC, Williams R, Mageed R Ann Rheum Dis (2012) 71: 1741-1748 4. Hull DN, Cooksley H, Chokshi S, Williams RO, Abraham S, Taylor PC Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis Arthritis Res Ther (2016) Vol 18 5. Bystrom J, Clanchy FI, Taher TE, Mangat P, Jawad AS, Williams RO, Mageed RA. TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases. Cytokine (2016).